EMAIL THIS PAGE TO A FRIEND

The Journal of clinical investigation

Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1.


PMID 26075824

Abstract

Macrophages clear millions of apoptotic cells daily and, during this process, take up large quantities of cholesterol. The membrane transporter ABCA1 is a key player in cholesterol efflux from macrophages and has been shown via human genetic studies to provide protection against cardiovascular disease. How the apoptotic cell clearance process is linked to macrophage ABCA1 expression is not known. Here, we identified a plasma membrane-initiated signaling pathway that drives a rapid upregulation of ABCA1 mRNA and protein. This pathway involves the phagocytic receptor brain-specific angiogenesis inhibitor 1 (BAI1), which recognizes phosphatidylserine on apoptotic cells, and the intracellular signaling intermediates engulfment cell motility 1 (ELMO1) and Rac1, as ABCA1 induction was attenuated in primary macrophages from mice lacking these molecules. Moreover, this apoptotic cell-initiated pathway functioned independently of the liver X receptor (LXR) sterol-sensing machinery that is known to regulate ABCA1 expression and cholesterol efflux. When placed on a high-fat diet, mice lacking BAI1 had increased numbers of apoptotic cells in their aortic roots, which correlated with altered lipid profiles. In contrast, macrophages from engineered mice with transgenic BAI1 overexpression showed greater ABCA1 induction in response to apoptotic cells compared with those from control animals. Collectively, these data identify a membrane-initiated pathway that is triggered by apoptotic cells to enhance ABCA1 within engulfing phagocytes and with functional consequences in vivo.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A1410
Actinomycin D, from Streptomyces sp., ~98% (HPLC)
C62H86N12O16
A9415
Actinomycin D, from Streptomyces sp., suitable for cell culture, ≥95%
C62H86N12O16
A4262
Actinomycin D, from Streptomyces sp., ≥95% (HPLC)
C62H86N12O16
01815
Actinomycin D, for fluorescence, ≥90% (HPLC), from Streptomyces sp.
C62H86N12O16
SAB2106639
Anti-ABCA1 antibody produced in rabbit, affinity isolated antibody
HPA042215
Anti-BRI3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2105133
Anti-CD5, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB4503585
Anti-CD5, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB2700788
Anti-EMR1 (C-terminal) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1405756
Anti-EMR1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA052809 Anti-EMR1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4500764
Anti-EMR1, C-Terminal antibody produced in rabbit, affinity isolated antibody
C8273
Cytochalasin D, from Zygosporium mansonii, ≥98% (TLC and HPLC), powder
C30H37NO6
C2618
Cytochalasin D, Ready Made Solution, from Zygosporium mansonii, 5 mg/mL in DMSO, 0.2 μm filtered
C30H37NO6
SAB1402677 Monoclonal Anti-ABCA1 antibody produced in mouse, clone 1H4, ascites fluid
SAB4100025
Monoclonal Anti-CD5 antibody produced in mouse, culture supernatant
SAB4700066 Monoclonal Anti-CD5 antibody produced in mouse, clone CRIS1, purified immunoglobulin, buffered aqueous solution
SAB4700071 Monoclonal Anti-CD5 antibody produced in mouse, clone MEM-32, purified immunoglobulin, buffered aqueous solution
SAB4700730 Monoclonal Anti-CD5 antibody produced in mouse, clone L17F12, purified immunoglobulin, buffered aqueous solution